AKT1 and ovarian cancer: The combined application of Mel and cisplatin can promote apoptosis in the human ovarian cancer cell line OVCAR3 and the osteosarcoma cell line MG63 by inhibiting the PI3K/Akt signalling pathway [42, 43].